Olymvax Biopharmaceuticals plans to issue H shares and list on the Hong Kong Stock Exchange
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, Olymvax Biopharmaceuticals announced that the company is planning to issue overseas shares (H shares) and apply for listing on the Hong Kong Stock Exchange (referred to as "Hong Kong Stock Exchange") to deepen its international strategic layout, enhance international visibility and influence, further optimize its capital structure, and strengthen its overall competitive strength
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments